A Newborn with Gastric Hemangioma Treated Using Propranolol
dc.authorid | turgut, hatice/0000-0002-0490-7852 | |
dc.authorwosid | gungor, sukru/JNR-9592-2023 | |
dc.authorwosid | Gökçe, İsmail Kürşad/ABI-8128-2020 | |
dc.authorwosid | turgut, hatice/IZQ-4154-2023 | |
dc.contributor.author | Kaya, Huseyin | |
dc.contributor.author | Gokce, Ismail Kursad | |
dc.contributor.author | Gungor, Sukru | |
dc.contributor.author | Turgut, Hatice | |
dc.contributor.author | Ozdemir, Ramazan | |
dc.date.accessioned | 2024-08-04T20:45:27Z | |
dc.date.available | 2024-08-04T20:45:27Z | |
dc.date.issued | 2018 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Gastric hemangiomas are rare benign vascular tumors that can cause severe gastrointestinal system bleeding. We presented the case of a neonate with fresh bleeding and melena from the orogastric tube and detected gastric hemangioma in esophagogastroduodenoscopic examination. Propranolol is widely used in treatment of cutaneous hemangiomas and non-gastric gastrointestinal system hemangiomas. However, the surgical approach is preferred for treating gastric hemangiomas, and there are few reports of gastric hemangiomas associated with non-surgical treatment. Gastric hemorrhage decreased with antacid and somatostatin treatment. Propranolol treatment was initiated before the surgery decision. After three weeks of treatment, we observed regression in the hemangioma with endoscopic evaluation. During the course of treatment, the patient's gastrointestinal system bleeding did not recur, and there were no side effects associated with propranolol. | en_US |
dc.identifier.doi | 10.5223/pghn.2018.21.4.341 | |
dc.identifier.endpage | 346 | en_US |
dc.identifier.issn | 2234-8646 | |
dc.identifier.issn | 2234-8840 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 30345249 | en_US |
dc.identifier.scopus | 2-s2.0-85054608932 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 341 | en_US |
dc.identifier.uri | https://doi.org/10.5223/pghn.2018.21.4.341 | |
dc.identifier.uri | https://hdl.handle.net/11616/98489 | |
dc.identifier.volume | 21 | en_US |
dc.identifier.wos | WOS:000446906200015 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Korean Soc Pediatric Gastroenterology & Nutrition | en_US |
dc.relation.ispartof | Pediatric Gastroenterology Hepatology & Nutrition | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hemangioma | en_US |
dc.subject | Newborn infant | en_US |
dc.subject | Propranolol | en_US |
dc.subject | Stomach | en_US |
dc.title | A Newborn with Gastric Hemangioma Treated Using Propranolol | en_US |
dc.type | Article | en_US |